Corvus Pharmaceuticals Announces Results of Preclinical Studies Demonstrating Enhanced Immune Responses and Anti-Tumor Activity with CPI-444, an Investigational Immuno-Oncology Therapy

World News: . []

BURLINGAME Calif April 19 2016 GLOBE NEWSWIRE -- Corvus Pharmaceuticals Inc NASDAQCRVS a clinical-stage biopharmaceutical LINK  focused on the development and commercialization of novel immuno-oncology therapies today LINK  resu lts of ...

More news and information about Corvus Pharmaceuticals

Published By:

Globe Newswire: 22:20 GMT Tuesday 19th April 2016

Published: .

Search for other references to "corvus" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us